We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease
We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
Updated: 6/15/2016
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
Updated: 6/15/2016
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
Updated: 6/15/2016
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
Updated: 6/15/2016
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
Updated: 6/15/2016
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
Updated: 6/15/2016
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
Updated: 6/15/2016
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
Updated: 6/15/2016
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Click here to add this to my saved trials
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
Updated: 6/15/2016
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
Updated: 6/15/2016
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Status: Enrolling
Updated: 6/15/2016
Click here to add this to my saved trials
New Non-invasive Methods for Real-time Monitoring of Organ Function.
Updated: 6/16/2016
New Non-invasive Methods for Real-time Monitoring of Organ Function.
Status: Enrolling
Updated: 6/16/2016
New Non-invasive Methods for Real-time Monitoring of Organ Function.
Updated: 6/16/2016
New Non-invasive Methods for Real-time Monitoring of Organ Function.
Status: Enrolling
Updated: 6/16/2016
Click here to add this to my saved trials
New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney Disease
Updated: 6/16/2016
Pilot and Feasibility Study: Evaluation of New Quantitative Magnetic Resonance Imaging Parameters in Assessing the Kidneys of Autosomal Dominant Polycystic Kidney Disease
Status: Enrolling
Updated: 6/16/2016
New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney Disease
Updated: 6/16/2016
Pilot and Feasibility Study: Evaluation of New Quantitative Magnetic Resonance Imaging Parameters in Assessing the Kidneys of Autosomal Dominant Polycystic Kidney Disease
Status: Enrolling
Updated: 6/16/2016
Click here to add this to my saved trials
Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD
Updated: 7/11/2016
Ellipsys Vascular Access Catheter System Clinical Trial
Status: Enrolling
Updated: 7/11/2016
Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD
Updated: 7/11/2016
Ellipsys Vascular Access Catheter System Clinical Trial
Status: Enrolling
Updated: 7/11/2016
Click here to add this to my saved trials
Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD
Updated: 7/11/2016
Ellipsys Vascular Access Catheter System Clinical Trial
Status: Enrolling
Updated: 7/11/2016
Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD
Updated: 7/11/2016
Ellipsys Vascular Access Catheter System Clinical Trial
Status: Enrolling
Updated: 7/11/2016
Click here to add this to my saved trials
Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD
Updated: 7/11/2016
Ellipsys Vascular Access Catheter System Clinical Trial
Status: Enrolling
Updated: 7/11/2016
Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD
Updated: 7/11/2016
Ellipsys Vascular Access Catheter System Clinical Trial
Status: Enrolling
Updated: 7/11/2016
Click here to add this to my saved trials
Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD
Updated: 7/11/2016
Ellipsys Vascular Access Catheter System Clinical Trial
Status: Enrolling
Updated: 7/11/2016
Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD
Updated: 7/11/2016
Ellipsys Vascular Access Catheter System Clinical Trial
Status: Enrolling
Updated: 7/11/2016
Click here to add this to my saved trials
Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD
Updated: 7/11/2016
Ellipsys Vascular Access Catheter System Clinical Trial
Status: Enrolling
Updated: 7/11/2016
Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD
Updated: 7/11/2016
Ellipsys Vascular Access Catheter System Clinical Trial
Status: Enrolling
Updated: 7/11/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Updated: 7/12/2016
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials
Volume,Sodium and Blood Pressure Management in HD
Updated: 7/14/2016
Fluid-Weight, Volume, Sodium, Blood Pressure Management in Hemodialysis by Limiting Intradialytic and Inter-dialytic Exposure to Sodium and Protocol-based Challenge of Post-dialysis Target Weight: A Pilot and Feasibility Trial
Status: Enrolling
Updated: 7/14/2016
Volume,Sodium and Blood Pressure Management in HD
Updated: 7/14/2016
Fluid-Weight, Volume, Sodium, Blood Pressure Management in Hemodialysis by Limiting Intradialytic and Inter-dialytic Exposure to Sodium and Protocol-based Challenge of Post-dialysis Target Weight: A Pilot and Feasibility Trial
Status: Enrolling
Updated: 7/14/2016
Click here to add this to my saved trials
Volume,Sodium and Blood Pressure Management in HD
Updated: 7/14/2016
Fluid-Weight, Volume, Sodium, Blood Pressure Management in Hemodialysis by Limiting Intradialytic and Inter-dialytic Exposure to Sodium and Protocol-based Challenge of Post-dialysis Target Weight: A Pilot and Feasibility Trial
Status: Enrolling
Updated: 7/14/2016
Volume,Sodium and Blood Pressure Management in HD
Updated: 7/14/2016
Fluid-Weight, Volume, Sodium, Blood Pressure Management in Hemodialysis by Limiting Intradialytic and Inter-dialytic Exposure to Sodium and Protocol-based Challenge of Post-dialysis Target Weight: A Pilot and Feasibility Trial
Status: Enrolling
Updated: 7/14/2016
Click here to add this to my saved trials
The Measurement of Insulin Resistance in Peritoneal Dialysis Patients
Updated: 7/18/2016
The Measurement of Insulin Resistance in Peritoneal Dialysis Patients
Status: Enrolling
Updated: 7/18/2016
The Measurement of Insulin Resistance in Peritoneal Dialysis Patients
Updated: 7/18/2016
The Measurement of Insulin Resistance in Peritoneal Dialysis Patients
Status: Enrolling
Updated: 7/18/2016
Click here to add this to my saved trials